Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01838512 · ClinicalTrials.gov registry record
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
A clinical trial of Multiple Myeloma, sponsored by Bristol-Myers Squibb.
- Active
- Registry status
- 2,555
- Enrollment target
- 20
- Study locations
NCT01838512: Active study of Multiple Myeloma, sponsored by Bristol-Myers Squibb.
NCT01838512 is a study of Multiple Myeloma that is active but no longer recruiting, run by Bristol-Myers Squibb. The registered enrollment target is 2,555 participants, above the 541-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (372% higher). The trial reports 20 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01838512, a study of Multiple Myeloma, is active but no longer recruiting, sponsored by Bristol-Myers Squibb.
- ACTIVE NOT RECRUITING
- Registry status
- 2,555 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to assess the clinical effectiveness of all approved multiple myeloma (MM) therapies in the newly-diagnosed (NDMM) and the relapsed/refractory MM (RRMM) settings in real-world clinical practice.
Conditions Studied
Study Locations (20)
California
- Local Institution - 0023 - Anaheim
- Local Institution - Anaheim
- Local Institution - 0045 - Burbank
- Local Institution - Corona
- Local Institution - 0048 - Downey
- Local Institution - 0052 - Fountain Valley
- Local Institute - Los Angeles
- Local Institute - Santa Rosa
- Local Institution - 0051 - Santa Rosa
Florida
- Local Institution - Brooksville
- Local Institution - 0044 - Fort Lauderdale
- Local Institution - Jacksonville
Georgia
- Local Institute - Valdosta
- Local Institution - 0047 - Valdosta
Illinois
- Local Institution - Skokie
- Local Institution - 0041 - Springfield
Indiana
- Local Institution - 0058 - Anderson
- Local Institution - 0011 - Indianapolis
Alabama
- Local Institution - Birmingham
Arizona
- Local Institute - Goodyear
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,555 participants |
| Start Date | 2012-06-13 |
| Est. Completion | 2030-03-31 |
What the registry record for NCT01838512 still lists
NCT01838512 is an observational study that tracks outcomes without assigning an intervention. Its 2,555 participants enrollment target places it among the larger protocols in the corpus, above the 541-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (372% higher).
The record links to 1 condition, with Multiple Myeloma appearing as the primary indexed condition, and to 0 interventions.
NCT01838512 names 20 study sites across 7 states, led by California, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT01838512 about?
NCT01838512 is a clinical study titled "Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)". The purpose of this study is to assess the clinical effectiveness of all approved multiple myeloma (MM) therapies in the newly-diagnosed (NDMM) and the relapsed/refractory MM (RRMM) settings in real-world clinical practice.
What is the current status of trial NCT01838512?
This trial is currently active not recruiting. The enrollment target is 2,555 participants. The study started on 2012-06-13. Estimated completion is 2030-03-31.
What conditions does trial NCT01838512 study?
This clinical trial studies the following conditions: Multiple Myeloma.
Who is sponsoring clinical trial NCT01838512?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01838512 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01838512's enrollment target sits among peer trials
2,555 11th of 438 higher than 428 of 438 other Multiple Myeloma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Myeloma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05931276 · 2,540 participants · Phase 3
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
- NCT06018285 · 2,572 participants · NA
Stepped Approach to Reducing Risk of Suicide in Primary Care
- NCT00018057 · 2,530 participants · Phase 2
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- NCT04142177 · 2,529 participants · NA
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI